世界经济论坛-加速生物制造革命（英）-2022.2-20页_1mb

Summary of "Accelerating the Biomanufacturing Revolution"

Core Content

The document outlines the opportunities and strategies for accelerating the biomanufacturing revolution, emphasizing its transformative potential across multiple industries. It highlights how advancements in synthetic biology and biotechnology are enabling sustainable, scalable, and innovative manufacturing solutions that can replace or enhance traditional industries.

Main Viewpoints

• Biomanufacturing is a powerful force that has the potential to redefine global manufacturing, particularly in the areas of sustainability, health, and materials.
• Cost reductions in DNA synthesis and sequencing, along with improvements in bioprocessing technologies, are driving the commercial viability of biomanufacturing.
• Strategic partnerships are critical for accelerating the development and adoption of biomanufacturing technologies, enabling faster prototyping, cost-sharing, and knowledge transfer.
• Workforce transformation is necessary to support the growing bioeconomy, with a focus on lifelong learning, upskilling, and aligning education with the needs of the biomanufacturing sector.
• Collaborative ecosystems are essential for overcoming challenges in scaling and commercializing biomanufacturing applications, especially in downstream processing and product integration.

Key Information

1. Strategic Partnerships and Investment

• Product Development Partnerships:

  • Platform companies such as Ginkgo Bioworks, Zymergen, and Amyris offer shared toolkits and infrastructure for biomanufacturing, reducing costs and increasing scalability.
  • These partnerships allow technology pioneers to test and develop applications without significant capital investment, while larger companies can explore new biomanufacturing solutions efficiently.
  • Examples include Lululemon and Genomatica collaborating on sustainable bio-nylon and Modern Meadow and Limonta forming BioFabbrica to accelerate performance biomaterials.

• Scaling the Deployment of New Solutions:

  • Scaling partnerships are vital for the commercialization of biomanufacturing, as they aggregate synergistic expertise and technologies.
  • Early prototyping is crucial to ensure product equivalence and compatibility with the intended application, and to avoid integration challenges later.
  • Current biomanufacturing capabilities are often limited by the lack of downstream processing infrastructure, which requires specialized equipment and expertise.

• Biomanufacturing Co-operatives:

  • These are public-private programs where organizations co-invest and co-design, helping to accelerate the development and testing of biomanufacturing applications.
  • They address the shared upstream needs and the more diverse downstream requirements, creating a more flexible and scalable ecosystem.

2. Workforce Transformation

• Emerging Opportunities:

  • The biomanufacturing revolution is creating new roles and skill sets across the manufacturing value chain, with applications in health, agriculture, consumer products, and materials.
  • These opportunities are not limited to urban centers but are expanding globally, requiring a more diverse and geographically distributed workforce.

• Workforce Strategy:

  • A focus on lifelong learning and upskilling is necessary to meet the evolving demands of the bioeconomy.
  • Drawing on best practices from adjacent industries such as ICT and pharmaceuticals, the workforce must be equipped with both technical and interdisciplinary skills.
  • The development of a highly trained local workforce is essential for biosecurity and global pandemic preparedness.

• Taking Action:

  • Organizations must invest in education and training programs to prepare the workforce for the future of biomanufacturing.
  • This includes creating partnerships between academia, industry, and government to support continuous education and innovation in the sector.

Community Call to Action

The World Economic Forum encourages leaders from the private and public sectors, academia, and civil society to collaborate on fostering a sustainable and innovative biomanufacturing ecosystem. This includes:

• Sharing emerging opportunities and best practices in biomanufacturing.
• Aligning on strategic priorities for public-private collaboration.
• Incubating pilot programs and new partnerships that support the development of biomanufacturing.

Conclusion

The biomanufacturing revolution is poised to transform industries and address global challenges such as sustainability, health, and biosecurity. To realize this potential, the document emphasizes the importance of strategic partnerships, investment in new technologies, and workforce transformation. By fostering a collaborative and innovative ecosystem, the biomanufacturing sector can accelerate its commercialization and contribute significantly to the growing bioeconomy.